Gilteritinib With Induction and Consolidation Chemotherapy for Newly Diagnosed AML: Preliminary Phase I Results

Slideset - Preliminary data suggest novel combination of gilteritinib and chemotherapy has antileukemic effect inFTL3-mutated AML with acceptable safety.
Source: Clinical Care Options Leukemia - Category: Hematology Source Type: research